1 / 15

Venous Thromboembolism Prophylaxis for Medical Inpatients

Venous Thromboembolism Prophylaxis for Medical Inpatients. Dennis Whang 4/2/12 DSR2 Mini Lecture. Objectives. Recognize the morbidity and mortality with venous thromboembolism of inpatients Determine the risk of VTE for each nonsurgical inpatient admitted

dominic-rutledge
Download Presentation

Venous Thromboembolism Prophylaxis for Medical Inpatients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Venous Thromboembolism Prophylaxis for Medical Inpatients Dennis Whang 4/2/12 DSR2 Mini Lecture

  2. Objectives • Recognize the morbidity and mortality with venous thromboembolism of inpatients • Determine the risk of VTE for each nonsurgical inpatient admitted • Decide the VTE prophylaxis for each nonsurgical inpatient admitted

  3. Background • Most medical inpatients are at risk for venous thromboembolism (VTE): • Deep venous thrombosis (DVT) • Pulmonary embolus (PE) • 25% of all VTE cases occur during hospitalization • 50-75% of VTE cases occur on medical service • 5-10% of inpatient deaths are due to PE • Heparin prophylaxis has NOT shown to decrease risk for inpatient mortality • However it has shown to decrease the incidence of PE

  4. Deciding VTE Prophylaxis • Must weigh TWO factors before deciding ppx • VTE Risk • Bleeding risk

  5. VTE Prophylaxis Guideline • Risk of VTE • Low risk if all 3: • Younger than 40 • Mobile • No thrombotic risk factors • Moderate risk: All other patients • High risk: ICU patients • High Bleeding Risk • Active gastroduodenal bleed • Bleeding within 3 months prior to admission • Platelet count of < 50

  6. Thrombotic Risk Factors for VTE • Obesity: BMI > 30 • Smoking • Immobility • Malignancy • Previous VTE • Placement of central venous catheter • Inherited or acquired hypercoagulable states • Oral contraceptives/Hormone replacement therapy/tamoxifen • Admission diagnosis of: • Congestive heart failure (NYHA III/VI) • Acute COPD exacerbation • Acute infectious disease or sepsis • Acute myocardial infarction • Stroke with lower limb paralysis • Inflammatory bowel disease

  7. Mechanical VTE Prophylaxis • Intermittent pneumatic compression • Contraindicated in leg ischemia from peripheral vascular disease • Ineffective in prevention of VTE • Graduated compression stockings • Venous foot pumps

  8. Pharmacological VTE Prophylaxis • Low dose unfractionated heparin (UFH) • 5,000 units SQ TID • Low molecular weight heparin (LMWH) • Enoxaparin (Lovenox) 40 mg SQ daily • Do NOT use if CrCl < 30 ml/min

  9. What VTE prophylaxis would you use? • A 62 yo F is admitted for community acquired pneumonia. No prior history of VTE, bleeding, hepatic, or renal failure. Her platelet count is 200. • Moderate risk of VTE • Low risk of bleeding • VTE ppx: unfractionated heparin or enoxaparin

  10. What VTE prophylaxis would you use? • A 35 yo M is admitted for acute gout. He is ambulatory. He has no prior VTE, GI bleed, thrombophilia, or malignancy. BMI 23. His platelet count is 240. • Low risk of VTE • Low risk of bleeding • VTE ppx: early ambulation

  11. What VTE prophylaxis would you use? • 21 yo F admitted to ICU for DKA from poor insulin compliance. She is ambulatory. She has no prior VTE, GI bleed, thrombophilia, or malignancy. Platelet count is 300. • High risk of VTE • Low bleeding risk • VTE ppx: unfractionated heparin or enoxaparin

  12. What VTE prophylaxis would you use? • A 65 yo F is admitted for treatment of an active malignancy. CrCl is 20 ml/min. She has a history of prior VTE but no history of bleeding, hepatic failure. Her platelet count is 250. • Moderate risk for VTE • Low bleeding risk • VTE ppx: unfractionated heparin

  13. VTE Prophylaxis Guideline • Risk of VTE • Low risk if all 3: • Younger than 40 • Mobile • No thrombotic risk factors • Moderate risk: All other patients • High risk: ICU patients • High Bleeding Risk • Active gastroduodenal bleed • Bleeding within 3 months prior to admission • Platelet count of < 50

  14. Summary • Be aware of VTE in all hospitalized patients • Assess risk of VTE with every admission • Use pharmacologic prophylaxis with heparin for patients with moderate to high risk of VTE • If pharmacologic prophylaxis is contraindicated due to high risk of bleeding, use intermittent pneumatic compression • Do not use compression stockings

  15. References • Guyatt GH, et al. Executive Summary : AntithromboticTherapyandPreventionofThrombosis, 9th ed: American College ofChestPhysiciansEvidence-Based Clinical Practice Guidelines. Chest 2012;141;7S-47S. • Francis, CW. ProphylaxisforThromboembolism in Hospitalized Medical Patients. N Engl J Med 2007;356:1438-44. • Pineo GF. Preventionofvenousthromboembolicdisease in medicalpatients. UpToDate, Mar 2012. • Qaseem A, et al. VenousThromboembolismProphylaxis in HospitalizedPatients: A Clinical Practice Guideline Fromthe American College ofPhysicians. Ann Intern Med. 2011;155:625-632.

More Related